Finance

Lists
LJUIF:OTCMKTS
SSY Group Ltd
USD 0,40
0,00%
(0,00) 1D
15 Sep., 12:06:41 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LJUIF...
Mkt. cap
7,70 mjd
Volume
0,00
52-wk high
USD 0,40
52-wk low
USD 0,40
Beta
0,21
Shares outstanding
2,95 mjd
No. of employees
5 k
Mkt. cap
7,70 mjd
Volume
0,00
52-wk high
USD 0,40
52-wk low
USD 0,40
Beta
0,21
Shares outstanding
2,95 mjd
No. of employees
5 k
News stories
From web sources and news partners
Profile
Lijun International Pharmaceutical (Holding) Co., Limited is a Wanchai, Hong Kong–based investment holding company with two pharmaceutical business segments: Wikipedia
About SSY Group Ltd
CEO-
Employees5,4 k
Founded1999
Headquarters-
SectorPharmaceutical industry
Websitessygroup.com.hk
Previous reportsAll values in HKD
Loading Previous Earnings...
Revenue
Net income
All values in HKD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,01 mjd
1,01 mjd
1,18 mjd
1,18 mjd
Cost of goods sold
588,81 m
588,81 m
694,08 m
694,08 m
Cost of revenue
588,81 m
588,81 m
694,08 m
694,08 m
Research and development expenses
53,89 m
53,89 m
48,48 m
48,48 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
296,21 m
296,21 m
238,84 m
238,84 m
Operating expense
308,00 m
308,00 m
263,56 m
263,56 m
Total operating expenses
896,81 m
896,81 m
957,64 m
957,64 m
Operating income
112,33 m
112,33 m
222,65 m
222,65 m
Other non operating income
-526,00 k
-526,00 k
-
-
EBT including unusual items
107,30 m
107,30 m
193,72 m
193,72 m
EBT excluding unusual items
90,07 m
90,07 m
193,72 m
193,72 m
Income tax expense
10,66 m
10,66 m
30,42 m
30,42 m
Effective tax rate
9,94%
9,94%
15,70%
15,70%
Other operating expenses
-40,25 m
-40,25 m
-27,91 m
-27,91 m
Net income
93,56 m
93,56 m
160,16 m
160,16 m
Net profit margin
9,27%
9,27%
13,57%
13,57%
Earnings per share
-
-
-
-
Interest and investment income
3,85 m
3,85 m
4,31 m
4,31 m
Interest expense
-25,39 m
-25,39 m
-25,98 m
-25,98 m
Net interest expenses
-21,54 m
-21,54 m
-21,67 m
-21,67 m
Depreciation and amortization charges
-
-
-
-
EBITDA
219,31 m
219,31 m
334,57 m
334,57 m
Gain or loss from assets sale
9,01 m
9,01 m
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme